Company news

Theratechnologies Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement

December 21, 2023

Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

August 21, 2023

Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Theratechnologies Inc.

May 19, 2023

Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 18, 2023

Theratechnologies to focus its commercialization activities on the North American territory

April 27, 2022

Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended

November 23, 2021

Theratechnologies Establishes New At-The-Market Facility

July 23, 2021

Change to Theratechnologies Management

March 2, 2020

Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo(TM) (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1

March 6, 2018

Shareholders elect new Board member during Theratechnologies' annual meeting

May 16, 2017

Announcements in conjunction with Theratechnologies annual meeting

May 16, 2017

Theratechnologies announces regretful decision by the Quebec Ministry of Health

June 9, 2016

Cott Corporation and Theratechnologies Under Current Evaluation

July 7, 2010

Investment Industry Regulatory Organization of Canada - Trade Resumption - Theratechnologies - TH

May 28, 2010

Investment Industry Regulatory Organization of Canada - Trading Halt - Theratechnologies Inc. - TH

May 27, 2010

Stocks slump at open

March 24, 2010

"Undervalued" Theratechnologies Inc. (OTC: THTCF) (TSE: TH)

October 22, 2009

Standard & Poor's annonce des modifications aux indices canadiens S&P/TSX

September 11, 2009

Market Regulation Services - Trade Resumption - Theratechnologies Inc. - TH

February 6, 2007

Market Regulation Services - Trading Halt - Theratechnologies Inc. - TH

February 6, 2007

Theratechnologies' common shares now eligible for inclusion in the SMB Growth Stock Plan

November 22, 2005

Theratechnologies: TH9507 Phase 3 study advancing rapidly

October 13, 2005

European pharmaceutical executive joins the Board of Theratechnologies

August 9, 2005

Theratechnologies: Financial results for the second quarter and recent operating highlights

July 13, 2005

Theratechnologies launches Phase III clinical trial for TH9507 (ThGRF) treating HIV-associated lipodystrophy

July 5, 2005

Theratechnologies closes the sale of its investment in Celmed BioSciences

June 20, 2005

Theratechnologies: four scientific posters at the Endocrine Society Annual Meeting

June 6, 2005

Theratechnologies reports on a positive meeting with Health Canada for its ThGRF Phase III program

May 4, 2005

PRESS CONFERENCE - Theratechnologies Inc. - Invitation to Media

April 13, 2005

Theratechnologies: Financial results for the first quarter of 2005 and recent operating highlights

April 13, 2005

PRESS CONFERENCE - Theratechnologies Inc. - Invitation to Media

April 11, 2005

Calls

The 5 newest of 18 calls. Every call is listed under its year.